Delivery Order SPE2DB20D9329-SPE2DB24FZJ47

Award Date 1/25/24
Potential Completion Date 2/15/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,919.35 contract is for the delivery of the contraceptive medical device Kyleena 19.5 MG Systems and has a completion date of November 15, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,611.58, is for the delivery of the contraceptive device Kyleena 19.5 mg Systems. The contract has a period of performance through May 28, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,718.30 contract is for the supply of the contraceptive device Kyleena 19.5 mg systems. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to issue orders for a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,757.76 contract is for the delivery of the contraceptive device KYLEENA 19.5 MG SYSTEMS and has an ultimate completion date of January 5, 2024. DMS Pharmaceutical Group Inc. also holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,070.20 award is for the provision of the contraceptive device Kyleena 19.5 mg Systems. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, which allows the agency to issue firm fixed-price delivery orders...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is valued at $5,718.30 and has an ultimate completion date of July 18, 2024. It was awarded on June 26, 2024 under the DLA's Medical Supply Chain program, which does not have a set-aside designation. DMS Pharmaceutical Group Inc. is the prime contractor and will be delivering Kyleena 19.5 mg...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,167.74 firm fixed-price contract is for the delivery of the contraceptive device Kyleena (19.5 mg systems) to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,335.48 contract is for the supply of the Kyleena 19.5 MG intrauterine contraceptive system. The award is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,611.58 fixed-price contract is for the delivery of the contraceptive device Kyleena 19.5 mg, with a performance period through January 13, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a total potential value of $1,203.84 and is for the delivery of the contraceptive device Kyleena 19.5 mg systems. The contract has a firm fixed price pricing type and a completion date of February 23, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery...
  • SPE2DB20D9329
    Indefinite Delivery Contract
  • SPE2DB20D9329-SPE2DB24FZJ47
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,239.20 contract is for the delivery of the contraceptive device Kyleena 19.5 mg systems. The award has a completion date of February 15, 2024 and is not associated with any set-aside designation.

DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which provides a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. This latest award is delivered through that overarching IDC vehicle, solidifying DMS Pharmaceutical Group's position as a key supplier in the federal pharmaceutical supply chain.

Generated 1/9/25, 9:23 AM